Xtant Medical Holdings, Inc.
$0.5
▼
-7.52%
2026-04-21 10:23:00
xtantmedical.com
ASE: XTNT
Explore Xtant Medical Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$75.1 M
Current Price
$0.5
52W High / Low
$0.95 / $0.39
Stock P/E
15.1
Book Value
$0.36
Dividend Yield
—
ROCE
11.26%
ROE
10.59%
Face Value
—
EPS
$0.03
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
—
Beta
-0.16
Debt / Equity
56.36
Current Ratio
2.65
Quick Ratio
1.63
Forward P/E
-24
Price / Sales
0.5
Enterprise Value
$78.9 M
EV / EBITDA
6.31
EV / Revenue
0.59
Rating
Strong Buy
Target Price
$1.1
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | MaxCyte, Inc. | $0.86 | — | $91.86 M | — | -24.06% | -23.63% | $2.96 / $0.64 | $1.61 |
| 2. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 3. | PROCEPT BioRobotics Corporation | $25.73 | — | $1.45 B | — | -23.48% | -24.89% | $66.85 / $19.35 | $6.5 |
| 4. | Zimmer Biomet Holdings, Inc. | $94.32 | 26.61 | $18.29 B | 1.04% | 6.61% | 5.6% | $108.29 / $84.59 | $64.95 |
| 5. | Sintx Technologies, Inc. | $2.78 | — | $11.46 M | — | -185.71% | -3.04% | $6.78 / $1.72 | $0.74 |
| 6. | Koninklijke Philips N.V. | $28.41 | 25.52 | $27.66 B | 0% | 7.46% | 7.82% | $27.7 / $19.09 | $13.43 |
| 7. | Picard Medical, Inc. | $0.9 | — | $69.69 M | — | -344.07% | 270.74% | $13.68 / $0.9 | $0.05 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 32.36 M | 33.26 M | 35.41 M | 32.9 M | 31.51 M | — |
| Operating Profit | -0.94 M | 2.54 M | 4.62 M | 1.06 M | -1.88 M | — |
| Net Profit | 0.06 M | 1.31 M | 3.55 M | 0.06 M | -3.17 M | — |
| EPS in Rs | 0 | 0.01 | 0.03 | 0 | -0.02 | -0.04 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 133.93 M | 117.27 M | 91.3 M | 57.97 M |
| Operating Profit | 7.28 M | -12.07 M | -10.16 M | -6.75 M |
| Net Profit | 4.97 M | -16.45 M | 0.66 M | -8.48 M |
| EPS in Rs | 0.04 | -0.12 | 0 | -0.06 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 94.14 M | 93.84 M | 92.61 M | 60.23 M |
| Total Liabilities | 43.19 M | 50.87 M | 41.26 M | 26.06 M |
| Equity | 50.95 M | 42.96 M | 51.35 M | 34.17 M |
| Current Assets | 78.25 M | 67.12 M | 64.87 M | 49.32 M |
| Current Liabilities | 29.48 M | 28.58 M | 22.99 M | 15.22 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 12.55 M | -11.9 M | -9.52 M | -5.34 M |
| Investing CF | 7.9 M | -3.73 M | -24.78 M | -1.56 M |
| Financing CF | -9.57 M | 16.07 M | 19.69 M | 9.02 M |
| Free CF | 10.16 M | -16.01 M | -10.97 M | -7.11 M |
| Capex | -2.38 M | -4.11 M | -1.46 M | -1.76 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 14.21% | 28.44% | 57.5% | — |
| Earnings Growth % | 130.23% | -2592.27% | 107.78% | — |
| Profit Margin % | 3.71% | -14.03% | 0.72% | -14.64% |
| Operating Margin % | 5.44% | -10.3% | -11.13% | -11.65% |
| Gross Margin % | 62.92% | 58.17% | 60.75% | 55.44% |
| EBITDA Margin % | 11.87% | -6.72% | 5.56% | -9.37% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.